Institutional Ownership
Rein Therapeutics Inc
CUSIP 00887A204COM NEWRNTXQ1 2026
Insider Transactions
33
Form 4 lines on record
Reporting Insiders
3
Distinct officers & directors
90d Buys
47.1K
Open-market purchase shares
90d Sells
0
Open-market sale shares
Insider Transactions — Form 4
33 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | May 27, 2026 | Von Rickenbach Josef H | Director | P · Buy | 4.5K | $1.07 | $4.8K | 62.5K | SEC |
| 2 | May 26, 2026 | Von Rickenbach Josef H | Director | P · Buy | 23.2K | $1.06 | $24.5K | 58.0K | SEC |
| 3 | May 22, 2026 | Von Rickenbach Josef H | Director | P · Buy | 15.9K | $1.05 | $16.7K | 34.8K | SEC |
| 4 | May 21, 2026 | Von Rickenbach Josef H | Director | P · Buy | 3.4K | $1.04 | $3.6K | 18.9K | SEC |
| 5 | May 8, 2026 | Windsor James Brian | See Remarks | A · Grant | 150.0K | — | — | 150.0K | SEC |
| 6 | Apr 30, 2026 | Windsor James Brian | See Remarks | P · Buy | 25.0K | $1.00 | $25.0K | 27.0K | SEC |
| 7 | Apr 1, 2019 | Novartis Bioventures Ltd | 10% Owner | S · Sell | 20.6K | $1.90 | $39.2K | 2.08M | SEC |
| 8 | Mar 29, 2019 | Novartis Bioventures Ltd | 10% Owner | S · Sell | 106.5K | $1.85 | $197.1K | 2.10M | SEC |
| 9 | Mar 15, 2019 | Novartis Bioventures Ltd | 10% Owner | S · Sell | 43.8K | $1.92 | $84.1K | 2.21M | SEC |
| 10 | Mar 14, 2019 | Novartis Bioventures Ltd | 10% Owner | S · Sell | 13.8K | $1.88 | $25.9K | 2.25M | SEC |
23 more insider transactions on Premium
See the full Form 4 transaction history for Rein Therapeutics Inc.
Unlock all transactions